ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
101,084.32
0.41%
S&P 500
6,040.53
-0.50%
Dow Jones
44,544.66
-0.75%
US Dollar vs Yen
155.195
-0.01%
Brent Oil
76.385
0.00%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. カナダ
  5. TSXV

  6. Acasti Pharma Inc (ACST) 銘柄情報

Acasti Pharma Inc

Acasti Pharma Inc (ACST)

Acasti Pharma Inc
0.58
0.00
(0.00%)
終了 2月2日 6:00AM
15分遅延

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

主要統計と詳細

通貨
0.58
買値
0.58
売値
0.98
出来高
-
0.00 日の範囲 0.00
0.58 52 週間の範囲 0.58
時価総額
5.451M
前日終値
0.58
始値
-
時刻
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
-
発行済株式数
9,399,000
配当利回り
-
PER
-2.46
1 株当たり利益 (EPS)
-1.37
歳入
-
純利益
-12.85M

Acasti Pharma Inc について

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
www.acastipharma.com
本社
Jersey City, New Jersey, USA
設立
-
Acasti Pharma Inc is listed in the Pharmaceutical Preparations sector of the トロントベンチャー取引所 with ticker ACST. The last closing price for Acasti Pharma was $0.58. Over the last year, Acasti Pharma shares have traded in a share price range of $ 0.58 to $ 0.58.

Acasti Pharma currently has 9,399,000 shares in issue. The market capitalisation of Acasti Pharma is $5.45 million. Acasti Pharma has a price to earnings ratio (PE ratio) of -2.46.

ACST 最新ニュース

その他のニュース

Acasti Pharma Reports Third Quarter 2023 Operational Results

Company to Host Conference Call Today at 1:00pm ET LAVAL, Québec, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a...

2023年2月14日
GlobeNewswire Inc.

Acasti Receives Extension to Regain Compliance with NASDAQ Minimum Bid Price Rule

LAVAL, Québec, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

2023年1月25日
GlobeNewswire Inc.

Acasti Pharma to Present at Lytham Partners Investor Select Conference on January 31

LAVAL, Québec, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

2023年1月25日
GlobeNewswire Inc.

Acasti Pharma to Present at Sidoti Virtual Investor Conference on January 18

LAVAL, Québec, Jan. 13, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

2023年1月13日
GlobeNewswire Inc.

Acasti to Host Conference Call on Tuesday, January 10, 2023 to Discuss Results from Recent Phase 1 PK Studies for GTX-101 and GTX-102 That Met All Outcome Measures

LAVAL, Québec, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

2023年1月5日
GlobeNewswire Inc.

Acasti Announces Preliminary Topline Results Met All Outcome Measures in the Pharmacokinetic Bridging Study for GTX-102, the Company’s Drug Candidate for the Treatment of Ataxia Telangiectasia

LAVAL, Québec, Dec. 28, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

2022年12月28日
GlobeNewswire Inc.

Acasti Pharma Announces Preliminary Topline Results Met All Primary Outcome Measures in the Single Dose Pharmacokinetic Study for GTX-101, the Company’s Drug Candidate for the Treatment of Postherpetic Neuralgia (PHN)

LAVAL, Québec, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

2022年12月22日
GlobeNewswire Inc.

Acasti Pharma Reports Second Quarter 2023 Operational Results

Company to Host Conference Call Today at 1:00pm ET LAVAL, Québec, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a...

2022年11月14日
GlobeNewswire Inc.

Acasti Pharma to Present at Q4 Investor Summit

LAVAL, Québec, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

2022年11月10日
GlobeNewswire Inc.

Acasti Pharma to Report Second Quarter 2023 Financial Results on Monday, November 14, 2022

LAVAL, Quebec, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three clinical...

2022年11月8日
GlobeNewswire Inc.
期間 †前日比前日比 %始値高値安値平均出来高VWAP
1000.580.580.5800CS
4000.580.580.5800CS
12000.580.580.5800CS
26000.580.580.5800CS
52000.580.580.5800CS
156-0.93-61.58940397351.511.660.4713671.03488033CS
260-0.37-38.94736842110.953.680.22933560.76256752CS

ACST - Frequently Asked Questions (FAQ)

What is the current Acasti Pharma share price?
The current share price of Acasti Pharma is $ 0.58
How many Acasti Pharma shares are in issue?
Acasti Pharma has 9,399,000 shares in issue
What is the market cap of Acasti Pharma?
The market capitalisation of Acasti Pharma is CAD 5.45M
What is the 1 year trading range for Acasti Pharma share price?
Acasti Pharma has traded in the range of $ 0.58 to $ 0.58 during the past year
What is the PE ratio of Acasti Pharma?
The price to earnings ratio of Acasti Pharma is -2.46
What is the reporting currency for Acasti Pharma?
Acasti Pharma reports financial results in USD
What is the latest annual profit for Acasti Pharma?
The latest annual profit of Acasti Pharma is USD -12.85M
What is the registered address of Acasti Pharma?
The registered address for Acasti Pharma is 103 CARNEGIE CENTER, SUITE 300 PRINCETON, JERSEY CITY, NEW JERSEY, 08540
What is the Acasti Pharma website address?
The website address for Acasti Pharma is www.acastipharma.com
Which industry sector does Acasti Pharma operate in?
Acasti Pharma operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
BYM.HBaymount Incorporated
$ 0.015
(200.00%)
102k
FBR.HFibre Crown Manufacturing Inc
$ 0.12
(140.00%)
10k
MPTH.HMapath Capital Corp
$ 0.035
(133.33%)
1,000
MMNMonarca Minerals Inc
$ 0.01
(100.00%)
10k
GETTGETT Gold Inc
$ 0.02
(100.00%)
1.1k
EKGCardioComm Solutions Inc
$ 0.01
(-50.00%)
79k
ADEAdex Mining Inc
$ 0.005
(-50.00%)
21.1k
MVYMoovly Media Inc
$ 0.005
(-50.00%)
1.3M
MURMurchison Minerals Ltd
$ 0.01
(-33.33%)
10k
AOROAloro Mining Corp
$ 0.01
(-33.33%)
59k
GXUGoviEx Uranium Inc
$ 0.035
(-30.00%)
50.83M
AISXAisix Solutions Inc
$ 0.05
(42.86%)
6.56M
CYGCygnus Metals Limited
$ 0.12
(-7.69%)
4.8M
GPUSAlset AI Ventures Inc
$ 0.105
(10.53%)
4.43M
QNCQuantum Emotion Corp
$ 0.81
(6.58%)
3.16M

議論

フィード全体を表示

最近閲覧した銘柄

TSXV
ACST
Acasti Pharma
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2025 ADVFN PLC - 全著作権所有

広告を削除する

サインアップして広告なしのエクスペリエンスを体験してください

広告なし

今すぐ試してください

広告を残す